Selim Corbacioglu
Overview
Explore the profile of Selim Corbacioglu including associated specialties, affiliations and a list of published articles.
Author names and details appear as published. Due to indexing inconsistencies, multiple individuals may share a name, and a single author may have variations. MedLuna displays this data as publicly available, without modification or verification
Snapshot
Snapshot
Articles
141
Citations
3351
Followers
0
Related Specialties
Related Specialties
Top 10 Co-Authors
Top 10 Co-Authors
Published In
Published In
Affiliations
Affiliations
Soon will be listed here.
Recent Articles
1.
Tometten M, Beier F, Kirschner M, Schumacher Y, Walter J, Vieri M, et al.
Blood Adv
. 2025 Feb;
PMID: 39938003
Pathogenic germline variants affecting proper telomere maintenance result in premature telomere shortening and cause telomere biology disorders (TBDs). While classical dyskeratosis congenita in children is rather well defined, late-onset ("cryptic")...
2.
Kleinschmidt K, Troeger A, Foll J, Hanafee-Alali T, Jakob M, Kramer S, et al.
EJHaem
. 2025 Jan;
6(1):e1094.
PMID: 39866932
Introduction: Veno-occlusive disease/sinusoidal obstruction syndrome (VOD/SOS) is a potentially life-threatening condition characterised by obstruction of the small veins of the liver. Although typically associated with haematopoietic stem cell transplantation, VOD/SOS...
3.
Ince E, Galimard J, Ifversen M, Dalissier A, Szmit Z, Mirci-Danicar O, et al.
Haematologica
. 2024 Nov;
PMID: 39605204
Not available.
4.
Kalwak K, Vora A, Bader P, Burkhardt B, Corbacioglu S, Drabko K, et al.
Br J Clin Pharmacol
. 2024 Nov;
91(3):882-893.
PMID: 39563212
Aims: Allogeneic haematopoietic stem cell transplantation (allo-HSCT) is a vital treatment for various paediatric malignant and nonmalignant diseases. The conditioning treatment before allo-HSCT is crucial for successful engraftment. Treosulfan, a...
5.
Torkler P, Sauer M, Schwartz U, Corbacioglu S, Sommer G, Heise T
Nat Commun
. 2024 Oct;
15(1):9121.
PMID: 39443485
RNA editing is a highly conserved process. Adenosine deaminase acting on RNA (ADAR) mediated deamination of adenosine (A-to-I editing) is associated with human disease and immune checkpoint control. Functional implications...
6.
Larue M, Labopin M, Brissot E, Alaskar A, Aljurf M, Arat M, et al.
Bone Marrow Transplant
. 2024 Oct;
60(1):28-31.
PMID: 39375526
This international questionnaire survey aimed to explore the current incidence, diagnostic policies, management, and outcomes of veno-occlusive disease/sinusoidal obstruction syndrome (VOD/SOS) among healthcare providers involved in the management of these...
7.
Aldebert C, Fahd M, Galimard J, Ghemlas I, Zecca M, Silva J, et al.
Bone Marrow Transplant
. 2024 Sep;
59(12):1717-1725.
PMID: 39289521
Congenital amegakaryocytic thrombocytopenia is a rare, inherited bone marrow failure syndrome. Allogeneic haematopoietic stem cell transplantation (allo-HSCT) is currently the only curative treatment. In this retrospective study, we analysed 66...
8.
Reger M, Manz K, Kaeuferle T, Coffey R, Wotschofsky Z, von Luettichau I, et al.
Pediatr Hematol Oncol
. 2024 Sep;
41(7):504-518.
PMID: 39235390
The COVID-19 pandemic affected daily life significantly and had massive consequences for healthcare systems with tremendous regional differences. This retrospective study aimed to investigate whether the pandemic and resulting societal...
9.
Lum S, Eikema D, Piepenbroek B, Wynn R, Samarasinghe S, Dalissier A, et al.
Blood
. 2024 Jul;
144(12):1329-1342.
PMID: 38968140
Allogeneic hematopoietic stem cell transplantation (HSCT) is the only established curative option for Fanconi anemia (FA)-associated bone marrow failure (BMF)/aplastic anemia (AA) and acute myeloid leukemia (AML)/myelodysplastic syndrome (MDS). We...
10.
Corbacioglu S, Lode H, Ellinger S, Zeman F, Suttorp M, Escherich G, et al.
Lancet Oncol
. 2024 Jun;
25(7):922-932.
PMID: 38936379
Background: Neuroblastoma is the most common extracranial solid tumour in children. Relapsed or refractory neuroblastoma is associated with a poor outcome. We assessed the combination of irinotecan-temozolomide and dasatinib-rapamycin (RIST)...